课题基金 / 基金详情

Stimulating Access to Research in Residency (StARR) - NHLBI

Stimulating Access to Research in Residency (StARR) - NHLBI
促进住院医师研究的机会 (StARR) - NHLBI
批准号:
10597856
负责人:
Mai ElMallah
金额:
$31.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-07-01 至 2028-06-30
关键词:
AchievementAddressAffectApplications GrantsAreaAwardBasic ScienceBiomedical ResearchBloodBlood VesselsBoard CertificationCardiopulmonaryCardiovascular systemCaringClinicClinicalClinical ResearchClinical TrialsCommunicationCommunitiesCountryCritiquesData ScienceDedicationsDevelopmentDevelopment PlansDiagnosisDiseaseDisparityDrug KineticsEducationEducational workshopEligibility DeterminationEnsureEvaluationExtramural ActivitiesFacultyFellowshipFosteringFoundationsFundingGoalsGrantHealthHealthcareHeartHeart DiseasesHematological DiseaseHumanIndividualInfrastructureInstitutionJournalsLaboratory ResearchLife Cycle StagesLungLung diseasesManuscriptsMedicalMedicineMentorsMentorshipMethodsMissionModalityModernizationNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseOperative Surgical ProceduresOutcomePathway interactionsPediatricsPeer ReviewPhasePhysiciansPhysicians&apos OfficesPositioning AttributeProductivityPublic HealthRequest for ApplicationsResearchResearch PersonnelResearch PriorityResearch Project GrantsResearch TrainingResidenciesResourcesScholarshipScientistSignal TransductionSocietiesStructureStudy SectionTimeTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkWritingcareercareer developmentclinical trainingclinical translationcoronavirus diseasedisorder preventionearly phase clinical trialexperiencehealth dataimplementation researchimprovedinnovationmedical schoolsmeetingsmultidisciplinarynext generationnovel diagnosticsnovel strategiesnovel therapeutic interventionpediatric departmentpreferencepreventprogramspublic health relevanceresponseskillssuccesstool

项目摘要

项目成果

Mai ElMallah的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT / PROJECT SUMMARY In response to a 30-year decline in the number of physician-scientists, attributed to prolonged clinical training, doubling or tripling of education debt, uncertain grant funding prospects, unclear career trajectories, and a lack of mentored research opportunities during early clinical training, the NIH started the Mentored ResearchPathway in Residency R38 program. Residency training, a critical step in physician training, is often carried out by training programs that do not support physician-scientist development. Significant gaps exist for protected research time, structured trainingand mentoring, and support to continue researchafter returningto the clinic. The primary goal of the multidisciplinary Duke NHLBI Scientist-Clinician-Investigator Stimulating access to Research during Residency (Duke SCI-StARR) program is to train a diverse cadre of physician-scientists who will lead the development, implementation, and evaluation of new clinical modalities to prevent, diagnose, and treat disease states affecting the heart, lungs, and blood throughout the life-course. Duke NHLBI SCI-StARR trainS residents across 3 departments: Pediatrics, Medicine, and Surgery in areas along the full biomedical research continuum (basic/translational, early phase clinical trials and pharmacokinetics, and late phase clinical trials and outcomes) with a theme of improving health over the life course. The program will consist of four training aims: 1) comprehensive didactics covering basic, translational, and clinical research and professional development; 2) development and completion of a research project and an individualized career development plan; 3) establishment of a track record of scholarly activity; and 4) eligibility for board certification and continuation to subspecialty training. Duke NHLBI SCI-StARR will be led by an Executive Committee (EC) of MPIs Mai K. ElMallah, MD (Pediatrics), Scott Palmer, MD, MHS (Medicine), and David Harpole, Jr., MD (Surgery), and an Expanded EC of Residency Program Directors and Program Coordinators, capitalizing on a team of 33 multi-departmental, multi-disciplinary, well-funded, and experienced faculty preceptors. This application requests support for three Resident-Investigators each year with each trainee to be supported for 18- 24 months of research. Upon completion of the program, these individuals will be capable of transitioning to research-intense fellowship training, successfully competing for extramural funding to support a path to independence as physician-scientists, and becoming the next generation of physicians leading and mentoring trainees in clinically-oriented research of disease states affecting the heart, lungs, and blood. Achievement of the program's objectives will fulfill urgent medical needs for: 1) more full-time academic physician-researchers and mentors in medical schools throughout the country and 2) innovations and clinical translation of novel strategies to improve the health of individuals across the life course.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1161/circgen.120.003131
发表时间: 2021-03
期刊: Circulation. Genomic and precision medicine
影响因子: --
作者: [Connell PS, Berkman AM, Souder BM, Pirozzi EJ, Lovin JJ, Rosenfeld JA, Liu P, Tunuguntla H, Allen HD, Denfield SW, Kim JJ, Landstrom AP]
通讯作者: Landstrom AP
DOI: 10.1111/cge.13968
发表时间: 2021-08
期刊: Clinical genetics
影响因子: 3.5
作者: []
通讯作者:
DOI: 10.1016/j.athoracsur.2020.04.101
发表时间: 2020-11
期刊: The Annals of thoracic surgery
影响因子: --
作者: [Weissler EH, Voigt SL, Raman V, Jawitz O, Doberne J, Anand J, Plichta R, Gaca JG, McCann RL, Hughes GC]
通讯作者: Hughes GC
DOI: 10.1007/s11886-020-01422-x
发表时间: 2020-10-10
期刊: Current cardiology reports
影响因子: 3.7
作者: [Regan JA, Shah SH]
通讯作者: Shah SH
16
    Respiratory Dysfunction in an Optineurin knock out ALS mouse model
    • 批准号:
      9978360
    • 项目类别:
    • 资助金额:
      $44.28万
    • 财政年份:
      2020
    • 负责人:
      Mai ElMallah
    • 依托单位:
    Targeted Therapy for Pompe Disease
    • 批准号:
      10621268
    • 项目类别:
    • 资助金额:
      $34.54万
    • 财政年份:
      2019
    • 负责人:
      Mai ElMallah
    • 依托单位:
    Targeted Therapy for Pompe Disease
    • 批准号:
      10202684
    • 项目类别:
    • 资助金额:
      $34.54万
    • 财政年份:
      2019
    • 负责人:
      Mai ElMallah
    • 依托单位:
    Targeted Therapy for Pompe Disease
    • 批准号:
      10017695
    • 项目类别:
    • 资助金额:
      $34.84万
    • 财政年份:
      2019
    • 负责人:
      Mai ElMallah
    • 依托单位:
    海外基金